Single-cell dynamics of breakthrough toxicities after anakinra prophylaxis for axicabtagene ciloleucel in lymphoma

Matthew J. Frigault(Harvard University), Marcela V. Maus(Center for Cancer Research), Kathleen Gallagher(Massachusetts General Hospital), Mark B. Leick(Massachusetts General Hospital), Trisha R. Berger(Harvard University), Yi‐Bin Chen(Massachusetts General Hospital), Simone Filosto(Kite (United States)), Caron A. Jacobson(Dana-Farber Cancer Institute), Zachariah DeFilipp(Harvard University), Richard Jeffrey(Harvard University), Nicholas J. Haradhvala(Broad Institute), Reid W. Merryman(Harvard University), Michael Trailor(Harvard University), Nora Horick(Massachusetts General Hospital), Areej El‐Jawahri(Massachusetts General Hospital), Rhine R. Shen(Broad Institute), P. Connor Johnson(Harvard University), Marc Wehrli(Broad Institute), Charlotte Graham(Broad Institute), Katelin Katsis(Harvard University), Jennifer L. Crombie(Dana-Farber Cancer Institute), Jenny Nater(Kite (United States)), Maria Dolaher(Massachusetts General Hospital), Hana Cho(Harvard University), Austin I. Kim(Dana-Farber Cancer Institute), Daniella Cook(Massachusetts General Hospital), Gad Getz(Broad Institute)
Blood Advances
February 10, 2025
Cited by 12


Related Papers